Challenges and Opportunities for Drug Development in Rare Disease or Small Populations

Wed, Aug 7, 2:00 PM - 3:50 PM

Lingyun LiuChairDong XiOrganizer

Biopharmaceutical Section

5 Presentations

2:05 PM - 2:25 PM

Yimeng Lu (VIR Biotechnology, Inc)

2:25 PM - 2:45 PM

Michael Kane (Yale University)

2:45 PM - 3:05 PM

Co-authors: Robert Beckman (Georgetown University), Cong Chen (Merck & Co., Inc.), Yi Liu (Nektar Therapeutics), Heng Xu (Nektar)

3:05 PM - 3:25 PM

Jialuo Liu (Gilead Sciences)

Co-authors: Dong Xi (Gilead Sciences)

3:25 PM - 3:45 PM

Peng Shi (Vertex)

Co-authors: Lingyun Liu, Bingming Yi (Vertex Pharmaceuticals), Glen Laird (Vertex Pharmaceuticals)

Glen Laird (Vertex Pharmaceuticals)